Plain-English translation of NCT06169449 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a structured weight management program—including diet, exercise, and ongoing support—can improve outcomes for overweight or obese patients with endometrial cancer who are being treated in a way that preserves their fertility. Research suggests that weight loss may help these patients achieve better remission rates, higher pregnancy rates, and lower recurrence rates. The study will compare patients who receive this guided weight management program to patients who receive standard care alone.
Obesity is known to reduce the effectiveness of fertility-preserving cancer treatment and increase the risk of cancer recurrence. While medical guidelines recommend weight management for these patients, there hasn't been enough research showing exactly how much a structured weight loss program helps. This trial aims to provide clear evidence about whether this treatment really works.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to either a weight management group or a routine care group. The weight management group will receive a structured program that includes personalized diet guidance, exercise recommendations, and ongoing support and encouragement from the study team. Both groups will have their body measurements, metabolism markers, and cancer outcomes monitored over time. The study involves 240 participants total and will track how well the weight management approach works compared to standard care.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China